2026 NPPES data Epilepsy Physician NPI 1346604683
Verify on CMS →

KASRA KERAMATIAN

Epilepsy Physician in SPRINGFIELD, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 423 beneficiaries · Epilepsy Physician avg: 878
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$686.97
31 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: KASRA KERAMATIAN is a Epilepsy Physician ([object Object]) practicing in SPRINGFIELD, Missouri with a Medicare Part D prescribing footprint of 2K claims across 423 beneficiaries — 6% brand-name prescribing . Industry payments of $686.97 across 31 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: KASRA KERAMATIAN filed 1,833 Medicare Part D claims in 2023 across SPRINGFIELD, Missouri. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

KASRA KERAMATIAN practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

KASRA KERAMATIAN at a glance

Quality data not reported

NPI registry status

Active

Issued 04/13/2016

NPI 1346604683

Primary specialty

Epilepsy Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

1,833 109% vs specialty avg

2023 prescription claims

Specialty avg: 878

Specialty distribution in Missouri

How Epilepsy Physician compares to other specialties among Missouri providers

Missouri providers

Epilepsy Physician share within Missouri

1. Epilepsy Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Epilepsy Physician share within Missouri

Specialty board-certification context

Estimated specialty board-certified rate — Epilepsy Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Epilepsy Physician ABMS/AOA estimate

Est. board-certified rate (Epilepsy Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Epilepsy Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KASRA KERAMATIAN is a Epilepsy Physician provider practicing in SPRINGFIELD, Missouri, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1346604683. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

KASRA KERAMATIAN appears in the CMS NPPES registry as a Epilepsy Physician provider at 3801 S NATIONAL AVE STE 900, SPRINGFIELD, MO, 65807, with a listed phone of (417) 875-3000. NPI 1346604683 was issued on 04/13/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KERAMATIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,833 prescription claims written by this provider, covering 423 Medicare beneficiaries and totaling roughly $200K in drug spend, split 6% brand-name and 94% generic by claim count, with an opioid prescribing rate of 1.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Epilepsy Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 878 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3801 S NATIONAL AVE STE 900
SPRINGFIELD, MO 65807

Provider Details

NPI 1346604683
Specialty Epilepsy Physician
Gender Male
NPI Issued 04/13/2016

Hospital and facility affiliations

Facilities where KASRA KERAMATIAN bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

LESTER E COX MEDICAL CENTERS
SPRINGFIELD, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KASRA KERAMATIAN. Source: openpaymentsdata.cms.gov.

Total received

$687

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

KASRA KERAMATIAN — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 1,833 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,833
Total Claims
$200K
Total Drug Cost
423
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,915
Total Day Supply
82,621
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$145K
Generic Drug Cost
$55K
Opioid Claims
18 (1.0% rate)

Patient Demographics

Average Patient Age
64.8 years
Avg HCC Risk Score
1.56
Gender Split
58% female / 42% male
Age Distribution
<65: 164, 65-74: 148, 75-84: 89, 85+: 22

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Gabapentin
149
Atorvastatin Calcium
124
Levetiracetam
124
Donepezil Hcl
94
Primidone
80
Lamotrigine
76
Lacosamide
65
Baclofen
60
Amitriptyline Hcl
55
Pregabalin
48

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Epilepsy Physician Overview

How KASRA KERAMATIAN fits within the Epilepsy Physician landscape nationally.

354
Epilepsy Physician Providers in US
42
States with Epilepsy Physician
878
Avg Claims per Provider

KASRA KERAMATIAN's 1,833 claims are above the specialty average of 878.

Nearby Epilepsy Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as KERAMATIAN.

Compare Epilepsy Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KASRA KERAMATIAN's specialty?
KASRA KERAMATIAN specializes in Epilepsy Physician and practices in SPRINGFIELD, Missouri.
How much does KASRA KERAMATIAN prescribe under Medicare Part D?
In 2023, KASRA KERAMATIAN wrote 1,833 Medicare Part D claims totaling $200K in drug costs for 423 beneficiaries.
Where is KASRA KERAMATIAN located?
KASRA KERAMATIAN is located at 3801 S NATIONAL AVE STE 900, SPRINGFIELD, MO, 65807. Phone: (417) 875-3000.
What is KASRA KERAMATIAN's NPI number?
KASRA KERAMATIAN's National Provider Identifier (NPI) is 1346604683, issued on 04/13/2016.
Does KASRA KERAMATIAN prescribe more brand-name or generic drugs?
KASRA KERAMATIAN's prescribing is 6% brand-name and 94% generic drugs by claim count, with $145K in brand drug costs.
Does KASRA KERAMATIAN prescribe opioids?
Yes, KASRA KERAMATIAN had 18 opioid claims in 2023 with an opioid prescribing rate of 1.0%.
How many Epilepsy Physician providers are there in the US?
There are 354 Epilepsy Physician providers across 42 states in the US. The average Epilepsy Physician provider writes 878 Medicare Part D claims per year.
What drugs does KASRA KERAMATIAN prescribe most often?
Based on 2023 Medicare Part D data, KASRA KERAMATIAN's most frequently prescribed drugs include Gabapentin, Atorvastatin Calcium, Levetiracetam. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KASRA KERAMATIAN accept Medicare?
KASRA KERAMATIAN appears in CMS Medicare data with 1,833 Part D claims and 423 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KASRA KERAMATIAN's credentials?
KASRA KERAMATIAN's NPI is 1346604683. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology